Monday, June 4, 2012

Dividend Income Analysis: Eli Lilly (LLY)

Eli Lilly & Co. (LLY) discovers, develops, manufactures, and sells pharmaceutical products worldwide. LLY is the 10th largest pharmaceutical company in the world and operates in the healthcare sector.  LLY used to be a strong dividend grower, but that growth has dried up since it made a large all-cash purchase of the biotechnology company ImClone.  LLY is the first company I put through my dividend income analysis.


No comments:

Post a Comment